A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma Interventions: Drug: pralatrexate; Dietary Supplement: Vitamin B12 and folic acid Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials